Pr. Nader RIFAI
Professor of Pathology at Harvard Medical School and the Louis Joseph Gay-Lussac Chair in Laboratory Medicine and the Director of Clinical Chemistry at Children’s Hospital in Boston, USA

Dr. Rifai’s major research interests have focused on the biochemical risk markers of coronary heart disease. He is the recipient of several scientific awards and has been an active member of several national and international professional societies. Dr. Rifai has recently been appointed the Editor-in-Chief of Clinical Chemistry, effective January 2008.